TY  - GEN
AU  - Kaufmann,Scott H
AU  - Karp,Judith E
AU  - Litzow,Mark R
AU  - Mesa,Ruben A
AU  - Hogan,William
AU  - Steensma,David P
AU  - Flatten,Karen S
AU  - Loegering,David A
AU  - Schneider,Paula A
AU  - Peterson,Kevin L
AU  - Maurer,Matthew J
AU  - Smith,B Douglas
AU  - Greer,Jacqueline
AU  - Chen,Yuhong
AU  - Reid,Joel M
AU  - Ivy,S Percy
AU  - Ames,Matthew M
AU  - Adjei,Alex A
AU  - Erlichman,Charles
AU  - Karnitz,Larry M
TI  - Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia
SN  - 1592-8721
PY  - 2012///0224
KW  - Acute Disease
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Benzoquinones
KW  - Checkpoint Kinase 1
KW  - Cytarabine
KW  - Female
KW  - HSP90 Heat-Shock Proteins
KW  - antagonists & inhibitors
KW  - Humans
KW  - Lactams, Macrocyclic
KW  - Leukemia
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Protein Kinases
KW  - metabolism
KW  - Recurrence
KW  - Time Factors
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3324/haematol.2011.049551
ER  -